PRAKASH DEVCHAND (70)
Chairman – CA (SA)
Prakash Devchand is a seasoned chartered accountant with more than 37 years of experience in the healthcare industry. He joined the Board of Lenmed in 1986 and assumed the roles of Chairman and Chief Executive Officer (CEO) in 1998. During his tenure as CEO, Prakash played a pivotal role in driving substantial growth within Lenmed’s local operations and spearheading the Group’s expansion into Africa. On 1 March 2020, Prakash transitioned from his role as CEO but continues to serve as Chairman and a valued member of the Board, bringing his wealth of industry expertise and strategic vision to guide Lenmed’s continued success and expansion efforts.
AMIL DEVCHAND (40)
Chief Executive Officer – CA (SA), GMP(HBS)
Amil Devchand joined the Lenmed Group in 2011 and has held several key positions, including Chief Financial Officer (CFO), Chief Operations Officer (COO), and Deputy Chief Executive Officer (CEO). As a chartered accountant with deep industry experience, Amil has served as the past chairman and current director of the National Hospital Network (NHN) and a former director of the Hospital Association of South Africa (HASA). He is also an alumnus of the Harvard Business School. Amil assumed the role of CEO of the Lenmed Group on 1 March 2020, bringing his extensive expertise and strategic leadership to guide the Group’s continued growth and success in the healthcare industry.
FREDRÉ MEIRING (49)
Chief Financial Officer – CA (SA)
Fredré Meiring was appointed as Chief Financial Officer (CFO) of Lenmed in 2019. A qualified chartered accountant, Fredré was previously partner and Chief Operating Officer (COO) of the Financial Advisory Division at Deloitte Africa. He brings over 20 years of extensive investment banking experience, specializing in debt and capital structuring and advisory across diverse industries. Fredré is affiliated with several organisations including the South African Institute of Chartered Accountants (SAICA), Association of Corporate Treasurers, and the South African Institute of Financial Markets. His wealth of expertise and industry insights contribute to driving Lenmed’s financial strategy and operational excellence.
MIKE MEEHAN (77)
Independent Non-Executive Director and Lead Independent Director – CA (SA)
Mike Meehan joined the Board of Lenmed in 2010, bringing extensive experience in executive and independent non-executive director roles across multiple companies listed on the Johannesburg Stock Exchange (JSE). Mike is a seasoned consultant, providing strategic planning, financial administration, and corporate management services to various companies and associations He is a member of the Institute of Directors in South Africa.
BHARTI HARIE (53)
Independent Non-Executive Director – BA LLB (Natal), LLM (Wits)
Bharti Harie joined the Board of Lenmed in 2010, bringing a wealth of legal expertise as an admitted attorney, notary and conveyancer. She currently serves on the Audit and Risk Committee and chairs the Remuneration and Nominations Committee. Bharti is an independent non-executive director on the boards of Ascendis Health Limited and Stefanutti Stocks Limited. Additionally, she holds a non-executive director position at Bell Equipment Sales South Africa, serves as vice-chair of Saint David’s Marist Inanda School, and contributes to the Marist Schools Council.
NOMAHLUBI SIMAMANE (65)
Independent Non-Executive Director –BSc (Honours) (University of Botswana and Swaziland), MA(USA)
Nomahlubi Simamane was appointed to the Board in 2012. Nomahlubi is the Chief Executive Officer (CEO) of Zanusi Brand Solutions (Pty) Limited, a brand consultancy firm. She serves on the boards of several companies including Hollard, Oceana and The Foschini Group. Nomahlubi’s achievements include winning the Top Businesswoman of the Year Award in the National Business Awards and being named Businesswoman of the Year at the Black Business Awards.
PROF. BHASKAR GOOLAB (76)
Non-Executive Director – MBBS (Bombay), FRCOG (London)
Professor Bhaskar Goolab was appointed to the Board in 1999. He is in private practice and is attached to the University of the Witwatersrand, where he is the head of the Department of Gynaecology and Endoscopy. Prof. Goolab’s leadership extends beyond academia; he was elected President of the South African Society of Obstetrics and Gynaecology in January 2012 and currently serves on the board of the International Society of Gynaecology and Endoscopy, where he chairs the training council for developing countries.
DR GUNVANT GOOLAB (62)
Independent Non-executive Director – MBA (University of Cape Town), MBBCh (Wits)
Dr. Gunvant Goolab, appointed to the Board in August 2020, brings extensive executive and healthcare industry experience to Lenmed. A qualified medical practitioner, Dr. Goolab previously served as principal officer of Government Employees Medical Scheme (GEMS) from 2013 to 2020 and held the role of Chief Executive Officer (CEO) at AstraZeneca SA (Pty) Limited in South Africa and sub-Saharan Africa from 2004 to 2013. Dr. Goolab currently serves as a director of Lunar Capital (Pty) Limited and – director of HiGain Investments (Pty) Limited. Dr Goolab also serves as a trustee of Thebemed medical scheme. In addition, he serves as a director of the Board of Healthcare Funders and Health Quality Assessment. In recognition of his leadership in governance, Dr. Goolab obtained the designation of certified director with the Institute of Directors in South Africa in 2021.
VAUGHAN FIRMAN (61)
Non-Executive Director – MBAcc, CA(SA), HDip Tax Law (Wits), MA and MPhil (both in USA)
Vaughan Firman is a qualified chartered accountant with over 20 years’ experience in the healthcare industry. His comprehensive experience as a financial director includes serving as both an executive as well as an independent non-executive director on numerous JSE- and non-JSE-listed companies. Vaughan’s expertise spans mergers and acquisitions, operational efficiencies, internal audit implementation, enterprise resource planning (ERP) systems execution and international taxation structuring. Vaughan’s contributions to the healthcare sector have been recognised with awards such as Healthcare CFO of the Year in 2021 and Best Emerging Markets CFO in Healthcare for 2020 in the Global CFO Excellence Awards category.
